Brain sections obtained from APP/PS1 transgenic mice after experimental phase I showed many AD-like pathological features (Figures 2(a)–2(o)), including extensive deposition of extracellular β-amyloid plaques, astrocytosis, and cerebral inflammation. This evidence concerns the gene APP and Alzheimer disease.